1. Home
  2. NNOX vs XBIT Comparison

NNOX vs XBIT Comparison

Compare NNOX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NANO-X IMAGING LTD

NNOX

NANO-X IMAGING LTD

HOLD

Current Price

$0.64

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.17

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNOX
XBIT
Founded
2011
2005
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical Electronics
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
66.8M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
NNOX
XBIT
Price
$0.64
$2.17
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
★ 1.3M
43.6K
Earning Date
04-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$147.55
N/A
Revenue Next Year
$81.13
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.66
$2.09
52 Week High
$4.71
$3.44

Technical Indicators

Market Signals
Indicator
NNOX
XBIT
Relative Strength Index (RSI) 34.95 40.04
Support Level N/A N/A
Resistance Level $0.81 $2.48
Average True Range (ATR) 0.07 0.04
MACD 0.00 0.00
Stochastic Oscillator 6.37 15.38

Price Performance

Historical Comparison
NNOX
XBIT

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: